These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8425181)

  • 1. Role of the BCR-ABL oncogene in human leukemia: fifteenth Richard and Hinda Rosenthal Foundation Award Lecture.
    Witte ON
    Cancer Res; 1993 Feb; 53(3):485-9. PubMed ID: 8425181
    [No Abstract]   [Full Text] [Related]  

  • 2. [Role of the three-dimensional distribution of abl and bcr genes in the formation of bcr/abl fusion gene in interphase neucleus].
    Zhang Q; Zhou SY; Liu XL; Niu C; Xu L; Chen SJ
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Mar; 22(3):197-9. PubMed ID: 12390759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bcr/Abl associated leukemogenesis in bcr null mutant mice.
    Voncken JW; Kaartinen V; Groffen J; Heisterkamp N
    Oncogene; 1998 Apr; 16(15):2029-32. PubMed ID: 9591787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Philadelphia chromosome-positive leukaemia: the translocated genes and their gene products.
    Allen PB; Morgan GJ; Wiedemann LM
    Baillieres Clin Haematol; 1992 Oct; 5(4):897-930. PubMed ID: 1308169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bcr: a negative regulator of the Bcr-Abl oncoprotein.
    Wu Y; Ma G; Lu D; Lin F; Xu HJ; Liu J; Arlinghaus RB
    Oncogene; 1999 Aug; 18(31):4416-24. PubMed ID: 10442632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The juxtaposition of ABL with BCR and risk for fusion may come at the time of BCR replication in late S-phase.
    Anastasi J; Moinuddin R; Daugherty C
    Blood; 1999 Aug; 94(3):1137-8. PubMed ID: 10454798
    [No Abstract]   [Full Text] [Related]  

  • 7. The BCR gene and philadelphia chromosome-positive leukemogenesis.
    Laurent E; Talpaz M; Kantarjian H; Kurzrock R
    Cancer Res; 2001 Mar; 61(6):2343-55. PubMed ID: 11289094
    [No Abstract]   [Full Text] [Related]  

  • 8. The involvement of Bcr in leukemias with the Philadelphia chromosome.
    Arlinghaus RB
    Crit Rev Oncog; 1998; 9(1):1-18. PubMed ID: 9754444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The Philadelphia chromosome: from the gene to therapeutic methods].
    Pérez-Losada J; González-Sarmiento R; Sánchez-García I
    Sangre (Barc); 1998 Apr; 43(2):127-35. PubMed ID: 9656774
    [No Abstract]   [Full Text] [Related]  

  • 10. Exon-skipping in BCR/ABL is induced by ABL exon 2.
    Lichty BD; Kamel-Reid S
    Biochem J; 2000 May; 348 Pt 1(Pt 1):63-9. PubMed ID: 10794714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BCR sequences essential for transformation by the BCR-ABL oncogene bind to the ABL SH2 regulatory domain in a non-phosphotyrosine-dependent manner.
    Pendergast AM; Muller AJ; Havlik MH; Maru Y; Witte ON
    Cell; 1991 Jul; 66(1):161-71. PubMed ID: 1712671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The bcr-abl gene in chronic myelogenous leukaemia.
    Sawyers CL
    Cancer Surv; 1992; 15():37-51. PubMed ID: 1451113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCR gene expression blocks Bcr-Abl induced pathogenicity in a mouse model.
    Lin F; Monaco G; Sun T; Liu J; Lin H; Stephens C; Belmont J; Arlinghaus RB
    Oncogene; 2001 Apr; 20(15):1873-81. PubMed ID: 11313935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular consequences of the BCR-ABL translocation in chronic myelogenous leukemia.
    Sawyers CL
    Leuk Lymphoma; 1993; 11 Suppl 2():101-3. PubMed ID: 8124222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The function of BCR/ABL and related proto-oncogenes.
    Gotoh A; Broxmeyer HE
    Curr Opin Hematol; 1997 Jan; 4(1):3-11. PubMed ID: 9050373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide containing the BCR oligomerization domain (AA 1-160) reverses the transformed phenotype of p210bcr-abl positive 32D myeloid leukemia cells.
    Guo XY; Cuillerot JM; Wang T; Wu Y; Arlinghaus R; Claxton D; Bachier C; Greenberger J; Colombowala I; Deisseroth AB
    Oncogene; 1998 Aug; 17(7):825-33. PubMed ID: 9779999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P210 BCR-ABL is complexed to P160 BCR and ph-P53 proteins in K562 cells.
    Campbell ML; Li W; Arlinghaus RB
    Oncogene; 1990 May; 5(5):773-6. PubMed ID: 2140598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein.
    Pendergast AM; Quilliam LA; Cripe LD; Bassing CH; Dai Z; Li N; Batzer A; Rabun KM; Der CJ; Schlessinger J
    Cell; 1993 Oct; 75(1):175-85. PubMed ID: 8402896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation.
    Wetzler M; Talpaz M; Van Etten RA; Hirsh-Ginsberg C; Beran M; Kurzrock R
    J Clin Invest; 1993 Oct; 92(4):1925-39. PubMed ID: 8408645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acute lymphoblastic leukemia: its clinical cure and molecular cure].
    Colomer Pujol D
    Med Clin (Barc); 1999 Apr; 112(13):495-6. PubMed ID: 10353115
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.